An-lu Shen

In vivo and in vitro studies of Danzhi Jiangtang capsules against diabetic cardiomyopathy via TLR4/MyD88/NF-κB signaling pathway

Zhaohui Fang, Rui Song, Peng Zhou, 2021, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Astragaloside IV protects diabetic cardiomyopathy against inflammation and apoptosis via regulating TLR4/MyD88/NF-κB signaling pathway

Jian-fei Peng, Peng Zhou, Hui Shi, 2022, Journal of Functional Foods.

Molecular docking and in vivo studies of liquiritin against acute myocardial infarction via TLR4/MyD88/NF-κB signaling

Peng Zhou, Shu-shu Wang, An-lu Shen, 2022, Italian Journal of Food Science.